NASDAQ:WHWK

Whitehawk Therapeutics Stock Insider Trading

*Your capital is at risk

$3.91

+0.120 (+3.17%)

At Close: Jul 21, 2026

Whitehawk Therapeutics Stock Insider Power

Based on the 76 latest insides trades, we have calculated the insider power to be positive at 1.70. In total, the insiders bought 22.18M and sold 705.36K WHWK shares in the last 76 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power (Last 76 transactions)	1.70
● Buy	22.18M shares
● Sell	705.36K shares
82% Buy Activity Strong Negative Correlation
Sell Signal Low Confidence Apr 16, 2026 Analysis Breakdown: Weakened by a contradictory positive Insider Power Score. Partially supported by a negative historical correlation. Confidence increased due to high data reliability score of 100.

Historical Insider Trades

Date	Type	Person	Role	Amount
Apr 01, 2026 Buy	Restricted Stock Units M-Exempt	Lennon David James Chief Executive Officer	CEO / President	775 828 Value: $2.75M
Apr 01, 2026 Buy	Common Stock M-Exempt	Lennon David James Chief Executive Officer	CEO / President	775 828 Value: $2.75M
Apr 01, 2026 Buy	Stock Option (right to buy) A-Award	Lennon David James Chief Executive Officer	CEO / President	831 148 Value: $2.94M
Apr 01, 2026 Buy	Restricted Stock Units M-Exempt	Giacobello Scott M. Chief Financial Officer	C-Suite Officer	473 902 Value: $1.68M
Apr 01, 2026 Buy	Stock Option (right to buy) A-Award	Giacobello Scott M. Chief Financial Officer	C-Suite Officer	300 677 Value: $1.06M
Apr 01, 2026 Buy	Common Stock M-Exempt	Giacobello Scott M. Chief Financial Officer	C-Suite Officer	473 902 Value: $1.68M
Apr 01, 2026 Buy	Restricted Stock Units M-Exempt	Ball Bryan See Remarks	Officer	366 532 Value: $1.30M
Apr 01, 2026 Buy	Stock Option (right to buy) A-Award	Ball Bryan See Remarks	Officer	250 058 Value: $885.2K
Apr 01, 2026 Buy	Common Stock M-Exempt	Ball Bryan See Remarks	Officer	366 532 Value: $1.30M
Apr 01, 2026 Buy	Stock Option (right to buy) A-Award	Dugan Margaret Chief Medical Officer	Officer	283 157 Value: $1.00M
Apr 01, 2026 Buy	Stock Option (right to buy) A-Award	Dornan David Chief Scientific Officer	Officer	282 340 Value: $999.5K
Mar 02, 2026 Sell	Common Stock S-Sale	Ball Bryan See Remarks	Officer	1 834 Value: $6K
Mar 02, 2026 Sell	Common Stock S-Sale	Giacobello Scott M. Chief Financial Officer	C-Suite Officer	2 594 Value: $9K
Mar 02, 2026 Sell	Common Stock S-Sale	Lennon David James Chief Executive Officer	CEO / President	5 100 Value: $16.9K
Mar 01, 2026 Buy	Restricted Stock Units M-Exempt	Giacobello Scott M. Chief Financial Officer	C-Suite Officer	6 750 Value: $26.4K
Mar 01, 2026 Buy	Common Stock M-Exempt	Ball Bryan See Remarks	Officer	5 000 Value: $19.6K
Mar 01, 2026 Buy	Restricted Stock Units M-Exempt	Ball Bryan See Remarks	Officer	5 000 Value: $19.6K
Mar 01, 2026 Buy	Common Stock M-Exempt	Giacobello Scott M. Chief Financial Officer	C-Suite Officer	6 750 Value: $26.4K
Mar 01, 2026 Buy	Restricted Stock Units M-Exempt	Lennon David James Chief Executive Officer	CEO / President	16 250 Value: $63.5K
Mar 01, 2026 Buy	Common Stock M-Exempt	Lennon David James Chief Executive Officer	CEO / President	16 250 Value: $63.5K
Dec 01, 2025 Buy	Common Stock J-Other	Dugan Margaret Insider	Other	0 Value: $0
Dec 01, 2025 Buy	Restricted Stock Units A-Award	Dugan Margaret Chief Medical Officer	Officer	55 309 Value: $125.0K
Dec 01, 2025 Buy	Stock option (right to buy) A-Award	Dugan Margaret Chief Medical Officer	Officer	650 000 Value: $1.47M
Jun 17, 2025 Buy	Stock Option (right to buy) A-Award	Zhao Baiteng Director	Director	40 006 Value: $81.6K
Jun 17, 2025 Buy	Stock Option (right to buy) A-Award	Zhao Baiteng Director	Director	40 006 Value: $81.6K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%^* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks